Phone app tracks symptoms to help lung cancer patients keep up exercise after surgery
Tests a smartphone app that tracks symptoms to support exercise after lung cancer surgery.
Key facts
- Who runs it
- Zhongshan People's Hospital, Guangdong, China
- Where
- Zhongshan, ChinaSee the site
- Trial code
- Registry title
- Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
- Status
- Recruiting
- People taking part
- 736 people, planned
- Started
- 1 Dec 2023
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- ePRO based Remote Symptom Management provide by a mobile phone app
- Record updated
- 4 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-75 who are about to have keyhole (video-assisted) lung surgery for suspected or diagnosed lung cancer and can use a smartphone app.
- Age
- 18-75 years
- Sex
- All sexes can join.
- Disease stage
- Lung cancer, or suspected lung cancer, that can be removed by surgery (resectable primary lung cancer).
- Earlier treatment
- People who had treatment before surgery to shrink the cancer (neoadjuvant therapy) or an earlier lung resection surgery cannot join.
Main reasons for not taking part
- Surgery changed to open chest surgery (open thoracotomy)
- ECOG score above 1
- Cannot exercise because of physical limits
- Steady systemic corticosteroid use within 1 month before enrollment
- Unresolved side effects above Grade 1 from earlier treatments
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age 18-75 years old
- preoperative clinical diagnosis or suspicion of resectable primary lung cancer
- Able to use smartphones and complete electronic questionnaires
- Signed informed consent
Who cannot take part
- conversions to open thoracotomy during surgery
- Received neoadjuvant therapy
- Previous lung resection surgery
- Continuous systemic corticosteroid use within 1 month before enrollment
- Unresolved toxicity above Grade 1 from previous treatments
- ECOG score > 1
- Unable to exercise due to physical limitations
- Significant comorbidities or medical history
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in China
- No.2 Sunwen East Rd.Zhongshan, ChinaContact: Xiaojuan YangTaking people
About the trial
What the trial wants to find out
Brief Summary: This randomized controlled trial aims to evaluate whether active remote symptom monitoring and management via a smartphone app utilizing electronic patient-reported outcomes (ePRO) can improve adherence to prescribed outpatient pulmonary rehabilitation exercises among postsurgical lung cancer patients. Eligible patients will use the app for perioperative care and be randomized to an intervention group receiving ePRO-based symptom monitoring with clinician feedback or a control group receiving ePRO without feedback. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. If proven effective, the app-enabled remote rehabilitation model can be scaled up to enhance recovery for more postoperative patients.
Read full original descriptionShow less
Due to slower-than-expected recruitment, an interim analysis was introduced through a protocol amendment. Before any unblinded between-group efficacy analysis, a blinded review of recruitment progress, data completeness, and outcome-data structure was conducted. Mean weekly exercise duration was subsequently added as a co-primary endpoint to complement the threshold-based exercise adherence outcome. The amendment and revised interim statistical framework were approved by the Ethics Committee before the formal interim analysis and incorporated into the updated study record.
The 2 groups in the trial
- Intervention GroupTreatment being tested
Participants randomized to the intervention group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28. Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management.
Treatment: ePRO based Remote Symptom Management provide by a mobile phone app
- Control GroupNo study treatment, for comparison
Participants randomized to the control group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28, without clinician alerts.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients
- Plain-language title
- Phone app tracks symptoms to help lung cancer patients keep up exercise after surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05990946, who can take part
- Record updated
- 4 September 2026